Table 1.

Patients characteristics

	Age	Gender	Weight	Height	Comorbidity	Drugs	Previous treatments	Other
Patient 1	92	F	70	1·68	NIDDM type 2, Brain Stroke, peripheral arterial disease	Antihypertensive drugs, anticoagulant, diabetic drugs	Surgical debridement
Patient 2	74	F	78	1·65	None	anxiolytics	Advanced dressings
Patient 3	76	F	94	1·62	NIDDM Type 2, Hypothyroidism, venous insufficiency	Diabetic drugs, Thyroid hormones	Surgical debridement, skin grafts, NWPT
Patient 4	83	M	72	1·70	Peripheral arterial disease, Hypertensive heart failure, NIDDM type 2, MGUS, prostate cancer, rheumatic polymyalgia	anticoagulant, diabetic drugs, Antihypertensive drugs, pain killers	Surgical debridement
Patient 5	84	F	58	1·65	Hypertension, venous insufficiency	Antihypertensive drugs, anticoagulant	Surgical debridement, skin grafts
Patient 6	80	M	53	1·76	Prostate cancer, peripheral arterial disease	Antihypertensive drugs, anticoagulant	Advanced dressings
Patient 7	51	F	62	1·50	Multiple sclerosis	Cortisone	Muscolocutaneous flaps	Stop for burn
Patient 8	69	F	65	1·70	Autograft for Acute Myeloid Leukaemia, hypertension	Antihypertensive drugs, anticoagulant	Surgical debridement	Worsening because of arteriovenous fistula.
Patient 9	73	M	60	1·60	Peripheral arterial disease, Hypertensive heart failure	Antihypertensive drugs, anticoagulant	Advanced dressings
Patient 10	75	F	43	1·60	Venous insufficiency	None	Surgical debridement, skin grafts, Acelluar dermal grafts
Patient 11	63	M	80	1·75	Hypertension, peripheral arterial disease, scleroderma	Antihypertensive drugs, cortisone	Medicazioni avanzate

NIDDM, non‐insulin‐dependent diabetes mellitus; NWPT, negative wound pressure therapy.